March 14th, 2010

Intense Blood Pressure and Lipid Control Doesn’t Aid Type 2 Diabetics. A clinical trial called Action to Control Cardiovascular Risk in Diabetes (ACCORD) indicates that therapies to lower cholesterol and control lipids doesn’t affect the rate of cardiovascular disease in type 2 diabetics.

The study indicates that the therapies don’t help with either fatal or nonfatal editions of the disease.

ACCORD looked at heart disease in type 2 diabetics through using three controls: blood sugar, intensive control of blood pressure, and treatment of multiple blood lipids.

Type 2 diabetics could reduce their risk of stroke by keeping their blood pressure in check, but that finding is conclusive with other medical studies.

William Cushman of the VA in Memphis was in charge of the study, and added the following comment:

“Our results also showed a higher risk of serious adverse events with more intensive blood pressure control. Diabetic patients should discuss their systolic blood pressure goal with their health care provider and, as with any treatment, weigh the risks and benefits of various treatments to lower blood pressure.”

Type 2 diabetics currently aren’t recommended to undertake cholesterol and lipid control treatments beyond standard practice.

Another expert warns the following of the findings: [the findings] “in no way detract from the important point that controlling blood pressure and LDL cholesterol levels reduce cardiovascular risk – not only in patients with diabetes, but in all patients with elevated levels”

Those who are newly diagnosed with Type II diabetes may find that the results of ACCORD are not relevant for them.  As always, anyone with a medical condition should consult with their medical practitioner for a treatment plan appropriate for them.

Source:

Web MD

Photo Credit; Stock Photo

Related Posts

Related posts brought to you by Yet Another Related Posts Plugin.